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A B S T R A C T
We describe a case of disseminatedMycobacterium tuberculosis (mTB) with prostatic abscess in a newly
diagnosed HIV patient in the United States. The patient is a 34 year-old male who presented with
respiratory symptoms and was diagnosed with HIV/AIDS complicated by disseminated mTB infection of
the lungs, liver, and prostate. His prostate showed abscess formation on imaging that required drainage
however he did not present with any genitourinary complaints. Our literature review revealed that
prostatic involvement in mTB in the form of granulomatous prostatitis is uncommon; however, abscess
formation is extremely rare and only few such cases have been published. Nearly 50% of the patients with
prostatic abscess formation present without symptoms and therefore a high level of suspicion should be
maintained; imaging should be performed early and prophylactic antibiotics for non-speciﬁc urinary
symptoms should be avoided as this may lead to drug resistance of mTB to ﬂouroquinolones.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Disseminated tuberculosis is deﬁned as the spread ofMycobac-
terium tuberculosis complex (mTB) to one or more organs via
hematogenous or lymphatic spread [12]. Even though pulmonary
system involvement is most common, extrapulmonary involve-
ment is seen in 10% of cases. Of which 30–40% of the patients with
extrapulmonary involvement will present with genitourinary
tuberculosis (GU TB) [9]. Amongst the GU organs, prostatic TB is
less common (<5%). Overall, the largest study of prostatic TB
prevalence was done by Sporer et al. where 100 cases of prostatic
TB were identiﬁed out of 728 disseminated TB autopsy cases [28].
These cases included prostatic involvement in the form of
granulomatous prostatitis and prostatic abscesses. Prostatic
abscesses are less common and only 5 such cases have been
reported in the United States [10,11,15,24,29,30]. In this case report,
we present a case of disseminated TB, including a prostatic abscess,
in a patient with new diagnosis of HIV. In addition, we review the
literature on prostatic abscess formation by mTB to identify
prevalence, symptomatology, treatment and prognosis of these
patients.
Case report
A 34-year-old Indonesian male presented with a four week
history of diffuse abdominal pain, nausea, vomiting, odynophagia,
dyspnea on exertion, and a 20-pound unintentional weight loss.
The patient had a past medical history signiﬁcant for intravenous
drug abuse, alcohol abuse and 15 packs per year smoking history.
The patient hadmoved to United States from Indonesia 7 years ago.
Physical exam revealed a cachectic male with oropharyngeal
candidiasis and crackles bilaterally. Diffuse abdominal tenderness
on palpation was also noted. Laboratory studies revealed a normal
complete blood count (CBC), hyponatremia with sodium of
122 mEq/L, and abnormal liver function tests: AST 442U/L, ALT
150U/L, and ALP 295U/L. A fourth-generation HIV antigen/
antibody test (Abbott Laboratories) was conﬁrmed positive with
a MultiSpot positive for HIV-1 antibodies. Hepatitis C antibody
testing was also reactive. Additional testing revealed a CD4 count
of 2 cells/mm3 and a HIV-1 titer of 427,000 copies/ml determined
by a Quantitative HIV-1 RNA PCR assay (COBAS AmpliPrep/COBAS
Taqman Analyzer, v2.0, Roche Diagnostics). Chest imaging was
concerning for either multifocal pneumonia and/or possible
opportunistic infection (Fig. 1A). Abdominal CT revealed necrotic
mesenteric lymphadenopathy (Fig. 1B), micro-abscesses in the
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liver (Fig. 1C), and a 2.92.42.0 cm ﬂuid attenuation collection
posterolateral to the prostate suggestive of an abscess (Fig. 1D-E).
Urine analysis showed 2+ protein, 1+ urobilinogen, 3 red blood
cells, and 2 white blood cells. Multiple routine urinary cultures
showed no growth. Three sputum samples were collected and all
showed 4+ acid-fast bacilli (AFB) (> 36 AFB organisms per ﬁeld of
view at 400magniﬁcation) by auramine-rhodamine stain and
grew pure Mycobacterium tuberculosis complex in less than 7days
post-collection in the BACTEC TM Mycobacterial Growth Indicator
Tube (MGIT). Following culture, drug sensitivity testing was
performed, and the mTB isolate was susceptible to ﬁrst line drugs,
including isoniazid (MIC-0.2mcg/mL), rifampin (MIC-1.0mcg/mL),
ethambutol (MIC-5.0 mcg/mL), pyrazinamide (MIC-100 mcg/mL)
and streptomycin (MIC-2.0mcg/mL). The patient was started on
rifampin–300mg twice daily, isoniazid–300mg daily,
pyrazinamide–1500mg daily and ethambutol–1200mg daily (RIPE
therapy). Antiretroviral therapy was not initiated at this time.
Twelve days later, on follow-up imaging, the prostatic abscess
remained unchanged and a CT guided approach was utilized to
drain the abscess. Purulent ﬂuid (2mL) was drained and sent for
AFB culture. The purulent ﬂuid revealed 4+ AFB by auramine-
rhodamine stain (Fig. 2A) and grew mTB complex. The direct
Kinyoun stain is shown in Fig. 2B. Patient clinically improved on
RIPE therapy and was discharged with isolation precautions.
3 weeks post discharge, antiretroviral therapy with dolutegravir
and Truvada (HAART) was initiated. Post-discharge (28 days), the
patient was brought to the emergency department with acute
onset of drowsiness and incomprehensible speech. The patient had
been compliant with his medications. At this point, differential
diagnosis of Immune reconstitution inﬂammatory syndrome
(IRIS), and a new opportunistic infection including toxoplasmosis
were considered. MRI of the brain revealed multiple ring
enhancing lesions with surrounding edema in the cerebral
hemispheres bilaterally, the midbrain, and the cerebellar hemi-
spheres bilaterally as well (Fig. 3A,B). The patient was started on
steroids, empiric toxoplasmosis therapy with pyrimethamine,
sulfadiazine, and folinic acid. HAART and mTB therapy were
continued. A lumbar puncture was performed that showed
cerebrospinal ﬂuid glucose of 54, protein of 116, RBC count of 7,
and WBC count of 0. The cryptococcal antigen was non-reactive.
Toxoplasmosis IgG was >5; however, Toxoplasma gondii PCR was
negative. The patient’s hospital stay was also complicated by both
hyponatremia and also hypertension attributed to SIADH. The
patient gradually improved on the aforementioned therapeutic
[(Fig._1)TD$FIG]
Fig. 1. (A) CT chest showing patchy involvement of the lung with nodules, one shown here measuring 3.1 cm in greatest dimension. (B) CT abdomen and pelvis showing
multiple low attenuation left sided mesenteric lymph nodes measuring 2.52.4 cm suggestive of necrotic lymphadenopathy (C) multiple microabscess of the liver (D) Mild
splenomegaly at 12.5 cm (E) Enlarged prostatewith heterogeneous lowattenuation areawith 2.9 cm2.0 cm area of ﬂuid attenuation at the left posterior aspect that appears
to arise from the prostate concerning for abscess, axial plane (F) prostatic abscess, sagittal plane.
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regimen and nearly twomonths later, brainMRI showed a decrease
in the size of the lesions. The patient’s mental status also improved
and the patient was deemed ﬁt for discharge. The patient was lost
to follow-up after relocating to another state.
Discussion
We report a rare case of disseminated mTB with a prostatic
abscess in the United States in a newly diagnosed patient with
AIDS. The patient group most commonly afﬂicted with dissemi-
natedmTB is the HIV/AIDS population (50–70%) [20]. As discussed,
involvement of the prostate is less common than involvement of
other GU organs [14]. When present, prostatic mTB commonly
manifests as granulomatous prostatitis. Literature review of
prostatic TB cases shows that prostatic abscess formation is
exceedingly rare. Worldwide, approximately 21 such cases have
been reported in the literature with most case reports from India
and Spain and only 5 such cases from United States (Table 1)
[1,3,4,7,8,16,17,19,23,25–27].
Even thoughmajority of the patients with GUmTB presentwith
symptoms of dysuria, changes in urinary ﬂow, urgency or
frequency, nearly 25% of the patients present with no GU
symptoms [22]. In the review of literature, amongst the patients
with prostatic abscesses, 11/21 patients presented with urinary
symptoms (52%). In our patient, no GU complaints were
documented and the prostatic abscess was an incidental ﬁnding
on CT of the abdomen and pelvis. Prostate speciﬁc antigen (PSA)
testing is not usually helpful since only rare instances of PSA
elevation have been noted in patients with GU involvement
Lanjewar and Maheshwari, 1994. Commonly, sterile pyuria and
hematuria are the most common ﬁndings. A high rate of suspicion
should be maintained in HIV/immunocompromised patients
presenting with urinary symptoms. It is important to not treat
dysuria symptoms in these patients with empiric antibiotic
therapy such as with ﬂuoroquinolones for presumable bacterial
UTI as this can lead to drug resistance to mTB as they have activity
against mTB [13].
Since mTB is acquired person through person through
aerosolized droplets, the infection initially affects the pulmonary
system. In an immunocompetent patient, granuloma formation
around the bacilli within the lung parenchyma can contain mTB
replication and prevent disease activation. However, in immuno-
compromised patients, speciﬁcally AIDS patients, granuloma
formation is inadequate due to altered functionality of CD4T
cells, macrophages, dendritic cells, neutrophils and ﬁbroblasts [6].
These immune-microenvironment alterations allow for uncon-
trolled mTB replication, higher chances of getting active infection
and distant spread. GU spread occurs through lymphatic spread,
hematogenous seeding, descending infection to urinary organs or
tract, direct extension from neighboring TB focus in the genital
tract, and rarely ascending infection through the urethra in cases of
BCG therapy. One or successive hematogenous seedings are the
most common mode of transmission Sporer and Auerbach, 1978.
Typically an extended (long) latency period of approximately
22 years exists between the ﬁrst pulmonary infection and
presentation of GU mTB Figueiredo and Lucon, 2008. Incongru-
ously, in this case, the patient presented with pulmonary
involvement and was diagnosed with disseminated TB including
hepatic, splenic, lymphatic and prostatic involvement
simultaneously.
[(Fig._3)TD$FIG]
Fig. 3. A and B. Representative axial images of MRI of the brain showing innumerable ring enhancing lesions with surrounding edema in both cerebral hemispheres (A),
bilateral basal ganglia, midbrain and cerebellar hemispheres (B).
[(Fig._2)TD$FIG]
Fig. 2. (A) 4+ AFB by auramine-rhodamine stain (B) Acid fast Kinyoun stain showing AFB stain positive organisms.
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Table 1
Outline of published literature on prostatic abscess cases due to mTB.
Year Country Immune
status
Number of
patients/
Organs
affected
Symptoms Imaging Treatment Follow up Case
1988 United
States
AIDS 1 case
prostatic,
pulmonary
and nodal TB
Cough, dyspnea US showed a prostatic lesion Transrectal puncture and
TB therapy
None described [24]
1994 United
States
AIDS (All had
CD4 count
<200 cells/ml)
7 cases/
unknown
Fever, irritative
voiding symptoms
TRUS Variable-surgical approach
and anti-tuberculosis
therapy
Not provided [29]
1995 Spain AIDS prostatic
abscess,
disseminated
TB
unknown TRUS Drainage and anti-
tuberculosis therapy
Recovered [8]
1996 India AIDS 2 patients;
1 with vague
urinary
symptoms
post-mortem prostatic abscesses not applicable not applicable [18]
1996 United
States
AIDS Not provided Not provided Not provided Not provided Not provided [30]
1997 United
States
BCG therapy prostatic
abscess,
disseminated
TB
Not provided Not provided Not provided Not provided [10]
2000 Australia HIV (Previous
history of
pulmonary
TB)
(CD4 count-
101 cells/ml)
prostate fever, dysuria,
perineal pain,
diarrhea
3 cm prostatic abscess RIPE (antiretroviral were
stopped due to interactions
with cytochrome
p450 system
resistant to
rifampin;
developed a
rectoprostatic
ﬁstula; treatment
continued with
other drugs
[5]
2001 Pakistan Immuno-
competent
2 cases of
isolated
Prostatic TB
acute urinary
retention
At cystoscopy, prostate was
enlarged
RIPE for 9 months Recovered [26]
2002 United
States
Known HIV
(CD4 count-
40 cells/ml)
prostatic TB fever, night sweats,
chills, dysuria
CT showed hypodense areas in
bilateral kidneys, multiple 1-
1.5 cm intraprostatic collections
with enhancing rims; enlarged
prostate (5 cm)
Transurethral
prostatectomy was done;
RIPE and HAART
none [11]
2003 India Immuno-
competent
prostate urinary retention heterogenous parenchymal
echotexture along with multiple
irregular cavitations in the
prostate
drugs and prostatectomy none [3]
2005 United
States
BCG therapy 1 case
prostatic
abscess
perineal pain,
dysuria, tenesmus,
strangury
Digital rectal examination aroused
suspicion of prostate infection
transurethral prostatic
resection produced white
copius secretions; RIPE
therapy
Recovered [2]
2006 India Immuno-
competent
prostatic pyrexia of unknown
origin
CT showed prostatic abscess;
1.9 cm on TRUS
TRUS guided drainage; TB
drugs started; one month
later still fevers; prostate
enlarged and extraprostatic
extension; now drained
Recovered [17]
2008 Spain Immuno-
competent
prostatic
abscess
fever, fatigue, weight
loss
infection in the right lobe of the
prostate
RIP for two months and IR
for next 10 months
normal [27]
2009 India Immuno-
compromised
(alcoholism)
cutaneous,
lung and
prostate
painful non healing
ulcers of lower lip
and scrotum, cough
low grade fever,
anorexia, dysuria
Not provided RIPE skin lesions
improved in
2 weeks; no
additional follow
up
[23]
2010 Malaysia HIV
(CD4 count-
91cells/ml)
prostatic
abscess
poor urinary ﬂow,
frequency, urgency
Transrectal US showed irregular
cystic lesion (4.5 cm)
RIPE lost to follow up [19]
2010 India Immuno-
competent
prostatic
abscess
fever, urinary
frequency, dysuria,
perineal pain
MRI showed a prostatic abscess
(7.7 cm)
drainage and 6months RIPE doing well in
15 year follow up
[25]
2012 Korea status post-
BCG therapy
prostate urinary frequency,
dysuria, perineal
discomfort
Oval shaped low density lesion drainage and RIPE no abscess after
12 months
[7]
2012 Portugal Known
history of HIV
(unknown
CD4 count)
disseminated
TB- CNS,
spleen, kidney
and prostate
fever, asthenia,
weight loss
CT showed splenomegaly with
multiple nodules and renal and
prostate bacesses (heterogeneous
areas with areas that were
hypodense); Brain CT showed
multiple suspicious
hypodensities; leptomeningeal
involvement
HRZE therapy and systemic
corticotherapy; intrathecal
corticotherapy; second line
drugs later used
(levoﬂoxacin, amycacin,
cycloserin)
patient died
10 months into
therapy and
continued to have
neurologic
degradation
[1]
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Common predisposing factors to prostatic abscess formation in
disseminatedmTB include immunosuppressionwhether it is in the
form of impaired cell mediated immunity, acquired immunodeﬁ-
ciency syndrome (AIDS) as in this case, prolonged immunosup-
pressants, or steroid use. Other patient populations at risk for
disseminated mTB, even though much more infrequent, include
patients with previous BCG therapy for bladder carcinoma and
immunocompetent patients. During the literature review, we
noted different patterns of mTB dissemination in these three
different patient populations. Most of the immunocompetent
patients with prostatic abscesses had isolated prostate involve-
ment bymTB (5/6). Only one case report documented involvement
of the prostate as part of disseminated TB, in an immunocompetent
host. In the BCG therapy population, 2/3 patients had isolated
prostate involvement with one developing miliary TB [7]. Lastly,
amongst the HIV/immunocompromised population, 4 patients had
disseminated disease alongside prostatic abscess formation while
11 patients had prostate only involvement [1,8,23,24]. It can be
theorized that the cases with disseminated TB including prostatic
abscess are likely under-reported in literature because extent of
visceral organ involvement even when present may not be well-
delineated or documented in such cases. These ﬁndings raise a
crucial clinical management issue- since immunocompromised
patients, particularly AIDS patients are at high risk for developing
prostatic abscess, it is crucial to get a transrectal ultrasound, CT or
MRI of the abdomen and pelvis to rule-out abscess formation. In
our patient, even though the prostatic abscess was identiﬁed early,
RIPE therapy could not penetrate the abscess wall and despite
weeks of treatment, the prostatic abscess imaging remained
unchanged. The standard of care therapy for these patients should
include prostatic abscess drainage in addition to mTB therapy as
was done in our case. Majority of the cases in the literature review
were treated similarly and did well. Only one patient died during
RIPE therapy and that was attributed to central nervous system
involvement by mTB.
Conclusion
Here, we presented a case of prostatic abscess formation as part
of disseminated TB in a patient with no GU symptoms and a new
AIDS diagnosis. In AIDS patients, it is important to keep a high
index of suspicion for prostatic abscess formation, perform
imaging early, avoid prophylactic antibiotics without culture
proven urinary tract infection, and treat with drainage and mTB
therapy.
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